These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits. Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610 [TBL] [Abstract][Full Text] [Related]
4. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Kaser S; Ebenbichler CF; Wolf HJ; Sandhofer A; Stanzl U; Ritsch A; Patsch JR Metabolism; 2001 Jun; 50(6):723-8. PubMed ID: 11398152 [TBL] [Abstract][Full Text] [Related]
6. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport. Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636 [TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713 [TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver. Gauthier A; Lau P; Zha X; Milne R; McPherson R Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327 [TBL] [Abstract][Full Text] [Related]
9. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Okamoto H; Yonemori F; Wakitani K; Minowa T; Maeda K; Shinkai H Nature; 2000 Jul; 406(6792):203-7. PubMed ID: 10910363 [TBL] [Abstract][Full Text] [Related]
10. Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: relationship to abnormalities in high-density lipoprotein. Hiraoka H; Yamashita S; Matsuzawa Y; Kubo M; Nozaki S; Sakai N; Hirano K; Kawata S; Tarui S Hepatology; 1993 Jul; 18(1):103-10. PubMed ID: 8325601 [TBL] [Abstract][Full Text] [Related]
11. High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. Zeller M; Masson D; Farnier M; Lorgis L; Deckert V; Pais de Barros JP; Desrumaux C; Sicard P; Grober J; Blache D; Gambert P; Rochette L; Cottin Y; Lagrost L J Am Coll Cardiol; 2007 Nov; 50(20):1948-55. PubMed ID: 17996559 [TBL] [Abstract][Full Text] [Related]
12. HDL and Cholesterol Ester Transfer Protein (CETP). Deng S; Liu J; Niu C Adv Exp Med Biol; 2022; 1377():13-26. PubMed ID: 35575918 [TBL] [Abstract][Full Text] [Related]
13. Structural features of cholesteryl ester transfer protein: a molecular dynamics simulation study. Lei D; Zhang X; Jiang S; Cai Z; Rames MJ; Zhang L; Ren G; Zhang S Proteins; 2013 Mar; 81(3):415-25. PubMed ID: 23042613 [TBL] [Abstract][Full Text] [Related]
14. Potential Inhibitors of the Activity of the Cholesterol-Ester Transfer Protein. Tárraga WA; Garda HA; Toledo JD; Gonzalez MC J Comput Biol; 2019 Dec; 26(12):1458-1469. PubMed ID: 31356116 [TBL] [Abstract][Full Text] [Related]
15. A depsipeptide fungal metabolite inhibitor of cholesteryl ester transfer protein. Hegde VR; Dai P; Patel M; Das PR; Wang S; Puar MS Bioorg Med Chem Lett; 1998 Jun; 8(11):1277-80. PubMed ID: 9871749 [TBL] [Abstract][Full Text] [Related]
16. Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein. Durley RC; Grapperhaus ML; Massa MA; Mischke DA; Parnas BL; Fobian YM; Rath NP; Honda DD; Zeng M; Connolly DT; Heuvelman DM; Witherbee BJ; Glenn KC; Krul ES; Smith ME; Sikorski JA J Med Chem; 2000 Nov; 43(24):4575-8. PubMed ID: 11101348 [No Abstract] [Full Text] [Related]
17. Dyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis. Minamisono T; Wada M; Akamatsu A; Okabe M; Handa Y; Morita T; Asagami C; Naito HK; Nakamoto S; Lewis LA; Mise J Clin Chim Acta; 1978 Mar; 84(1-2):163-72. PubMed ID: 639300 [No Abstract] [Full Text] [Related]
18. CRP, IL‑2 and TNF‑α level in patients with uremia receiving hemodialysis. Li G; Ma H; Yin Y; Wang J Mol Med Rep; 2018 Feb; 17(2):3350-3355. PubMed ID: 29257244 [TBL] [Abstract][Full Text] [Related]
19. An abnormal lipoprotein in the serum of uremic patients maintained on chronic hemodialysis. Papadopoulos NM; Borer WZ; Elin RJ; Diamond LH Ann Intern Med; 1980 May; 92(5):634-5. PubMed ID: 7387005 [No Abstract] [Full Text] [Related]
20. Complementary use of counter-current chromatography and hydroxyapatite chromatography for the separation of three main classes of lipoproteins from human serum. Shibusawa Y; Mugiyama M; Matsumoto U; Ito Y J Chromatogr B Biomed Appl; 1995 Feb; 664(2):295-301. PubMed ID: 7780580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]